Skip to content

Clinical trials

Completed Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Status: Completed Clear all

71 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20022
20033
20051
20061
20072
20095
20105
20112
20121
20133
20141
20152
20163
20178
20187
20197
20203
20213
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed71

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)6
Dana-Farber Cancer Institute2
Genmab2
Incyte Biosciences International Sàrl2
Jacobio Pharmaceuticals Co., Ltd.2
Washington University School of Medicine2
Baylor College of Medicine1
Cascadian Therapeutics Inc.1
Celldex Therapeutics1
Centre hospitalier de l'Université de Montréal (CHUM)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck71
Head and Neck Neoplasms27
Carcinoma, Non-Small-Cell Lung15
Carcinoma, Renal Cell9
Melanoma8
Breast Neoplasms7
Colorectal Neoplasms7
Esophageal Neoplasms7
Salivary Gland Neoplasms7
Ovarian Neoplasms6

Trials

Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.